Walleye Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Walleye Trading’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-119,720	Closed	-$2.26M	–	4865
2019 Q3	$2.26M	Buy	+119,720	New	+$1.37M	0.02%	940
2015 Q4	–	Sell	-700	Closed	-$23K	–	5933
2015 Q3	$23K	Buy	700 +600	+600%	+$25.5K	﹤0.01%	4006
2015 Q2	$5K	Buy	+100	New	+$3.64K	﹤0.01%	4519

Walleye Trading's ALDR Position: Q4 2019 in Review

Walleye Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 119,720 shares — an estimated $2.26M sold.

Walleye Trading first reported a position in ALDR in Q2 2015 and held it in 3 quarters. The position peaked at $2.26M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Walleye Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Walleye Trading sold 119,720 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.26M.
Walleye Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 3 quarters.
Walleye Trading's Alder Biopharmaceuticals position peaked at $2.26M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Walleye Trading's 13F filing for Q4 2019, filed 14 Feb 2020.